
Leukocyte-poor PRP effective and safe versus placebo for symptomatic knee OA treatment

Leukocyte-poor PRP effective and safe versus placebo for symptomatic knee OA treatment
Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial
Am J Sports Med. 2016 Apr;44(4):884-91Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
30 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized to receive three weekly intra-articular injections of either leukocyte-poor platelet rich plasma (LP-PRP) autologous conditioned plasma or placebo saline. The purpose of this study was to determine if LP-PRP administration demonstrated efficacy for improvement in pain, stiffness, and function on the Western Ontario...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.